147 related articles for article (PubMed ID: 35576331)
1. A Revised Markov Model Evaluating Oophorectomy at the Time of Hysterectomy for Benign Indication: Age 65 Years Revisited.
Rush SK; Ma X; Newton MA; Rose SL
Obstet Gynecol; 2022 May; 139(5):735-744. PubMed ID: 35576331
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk after hysterectomy with and without salpingo-oophorectomy for benign indications.
Chow S; Raine-Bennett T; Samant ND; Postlethwaite DA; Holzapfel M
Am J Obstet Gynecol; 2020 Dec; 223(6):900.e1-900.e7. PubMed ID: 32585221
[TBL] [Abstract][Full Text] [Related]
3. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
[TBL] [Abstract][Full Text] [Related]
4. Practice variation in bilateral salpingo-oophorectomy at benign abdominal hysterectomy: a population-based study.
Cusimano MC; Moineddin R; Chiu M; Ferguson SE; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2021 Jun; 224(6):585.e1-585.e30. PubMed ID: 33359174
[TBL] [Abstract][Full Text] [Related]
5. The risk of stroke after bilateral salpingo-oophorectomy at hysterectomy for benign diseases: A nationwide cohort study.
Lai JC; Chou YJ; Huang N; Chen HH; Wang KL; Wang CW; Shen IH; Chang HC
Maturitas; 2018 Aug; 114():27-33. PubMed ID: 29907243
[TBL] [Abstract][Full Text] [Related]
6. Bilateral salpingo-oophorectomy at the time of benign hysterectomy among females with disabilities: a population-based cross-sectional study.
Scime NV; Brown HK; Metcalfe A; Simpson AN; Brennand EA
Am J Obstet Gynecol; 2023 Dec; 229(6):658.e1-658.e17. PubMed ID: 37544349
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of hysterectomy with bilateral salpingo-oophorectomy: a systematic review and meta-analysis.
Hassan H; Allen I; Sofianopoulou E; Walburga Y; Turnbull C; Eccles DM; Tischkowitz M; Pharoah P; Antoniou AC
Am J Obstet Gynecol; 2024 Jan; 230(1):44-57. PubMed ID: 37364803
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy.
Chan JK; Urban R; Capra AM; Jacoby V; Osann K; Whittemore A; Habel LA
Obstet Gynecol; 2014 Jan; 123(1):65-72. PubMed ID: 24463665
[TBL] [Abstract][Full Text] [Related]
10. Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
Sasse SA; Lee SS; Rajeev P; Sharma SR; Kahan T; Pothuri B
Gynecol Oncol; 2023 Dec; 179():131-137. PubMed ID: 37988946
[TBL] [Abstract][Full Text] [Related]
11. Unnecessary bilateral salpingo-oophorectomy at the time of hysterectomy and potential for ovarian preservation.
Wong J; Murji A; Sunderji Z; Chow O; Shapiro J; Wolfman W; Shirreff L
Menopause; 2020 Sep; 28(1):8-11. PubMed ID: 32898023
[TBL] [Abstract][Full Text] [Related]
12. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
[TBL] [Abstract][Full Text] [Related]
13. Excess morbidity and mortality associated with underuse of estrogen replacement therapy in premenopausal women who undergo surgical menopause.
Ferris JS; Suzuki Y; Prest MT; Chen L; Elkin EB; Hur C; Hershman DL; Wright JD
Am J Obstet Gynecol; 2024 Jun; 230(6):653.e1-653.e17. PubMed ID: 38365100
[TBL] [Abstract][Full Text] [Related]
14. Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
Assaf W; Andraous M; Lavie O; Segev Y
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():48-54. PubMed ID: 35279641
[TBL] [Abstract][Full Text] [Related]
15. Reoperation and pain-related outcomes after hysterectomy for endometriosis by oophorectomy status.
Long AJ; Kaur P; Lukey A; Allaire C; Kwon JS; Talhouk A; Yong PJ; Hanley GE
Am J Obstet Gynecol; 2023 Jan; 228(1):57.e1-57.e18. PubMed ID: 36029832
[TBL] [Abstract][Full Text] [Related]
16. In-hospital complications of bilateral salpingo-oophorectomy at benign hysterectomy: a population-based cohort study.
Lai JC; Chen HH; Chu KH; Wang KL; Huang N; Hu HY; Chou YJ
Menopause; 2017 Feb; 24(2):187-195. PubMed ID: 27779566
[TBL] [Abstract][Full Text] [Related]
17. Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages.
Gierach GL; Pfeiffer RM; Patel DA; Black A; Schairer C; Gill A; Brinton LA; Sherman ME
Menopause; 2014 Jun; 21(6):592-601. PubMed ID: 24253486
[TBL] [Abstract][Full Text] [Related]
18. Intention matters: Success rate of bilateral salpingo-oophorectomy at the time of vaginal hysterectomy for pelvic organ prolapse.
Messingschlager C; Ferrando CA; Chang OH
Eur J Obstet Gynecol Reprod Biol; 2023 Apr; 283():54-58. PubMed ID: 36773471
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Gynecologic Surgery at Time of Colectomy Benefits Women with Lynch Syndrome and Colon Cancer: A Markov Cost-Effectiveness Analysis.
Ofshteyn A; Jiang B; Bingmer K; Nakayama JM; Gallego C; Giglia M; Stein SL; Steinhagen E
Dis Colon Rectum; 2020 Oct; 63(10):1393-1402. PubMed ID: 32969882
[TBL] [Abstract][Full Text] [Related]
20. Use of Estrogen Therapy After Surgical Menopause in Women Who Are Premenopausal.
Suzuki Y; Huang Y; Melamed A; Clair CMS; Hou JY; Khoury-Collado F; Gockley A; Accordino M; Hershman DL; Wright JD
Obstet Gynecol; 2022 May; 139(5):756-763. PubMed ID: 35576334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
